RE: IMC21 Aug 2025 19:10
Right, let me get this straight... SkinBioTherapeutics reports a £4.8m cash pile, which includes their recent £4.2m fundraise. Fine so far. But then, crickets on where the extra cash actually comes from.
Croda has them tied up in an NDA supposedly. Fair enough. But what about the acquisitions? Dermatonics, Bio-Tech Solutions, those deals aren’t hush-hush, are they? So why on earth aren’t they giving investors any clue about the cash impact there? No breakdown, no guidance, nada.
Leaving it wide open like this just fuels endless speculation in forums and chat rooms. Feels a bit like they’re banking on confusion to keep the story afloat. Investors deserve better transparency on their cash flows, especially from stuff they actually control.
Very concerning, they decided to leave it open to speculation for months, by deliberate design, re let gerbils do the promoting of expectation.